86 related articles for article (PubMed ID: 12237117)
1. Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells.
Postovit LM; Dutt P; Dourdin N; Park M; Greer PA; Graham CH; Elce JS
Biochem Biophys Res Commun; 2002 Sep; 297(2):294-301. PubMed ID: 12237117
[TBL] [Abstract][Full Text] [Related]
2. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts.
Dourdin N; Bhatt AK; Dutt P; Greer PA; Arthur JS; Elce JS; Huttenlocher A
J Biol Chem; 2001 Dec; 276(51):48382-8. PubMed ID: 11602605
[TBL] [Abstract][Full Text] [Related]
3. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
4. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
Sappino AP; Huarte J; Belin D; Vassalli JD
J Cell Biol; 1989 Nov; 109(5):2471-9. PubMed ID: 2509486
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
7. Conditional disruption of ubiquitous calpains in the mouse.
Tan Y; Dourdin N; Wu C; De Veyra T; Elce JS; Greer PA
Genesis; 2006 Jun; 44(6):297-303. PubMed ID: 16783822
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
[TBL] [Abstract][Full Text] [Related]
9. c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells.
Laderoute KR; Calaoagan JM; Knapp AM; Mendonca HL; Johnson RS
Biochem Biophys Res Commun; 2001 Jun; 284(5):1134-9. PubMed ID: 11414701
[TBL] [Abstract][Full Text] [Related]
10. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
15. The calpain small subunit regulates cell-substrate mechanical interactions during fibroblast migration.
Undyala VV; Dembo M; Cembrola K; Perrin BJ; Huttenlocher A; Elce JS; Greer PA; Wang YL; Beningo KA
J Cell Sci; 2008 Nov; 121(Pt 21):3581-8. PubMed ID: 18840650
[TBL] [Abstract][Full Text] [Related]
16. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
Piedagnel R; Tiger Y; Lelongt B; Ronco PM
J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
[TBL] [Abstract][Full Text] [Related]
17. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
[TBL] [Abstract][Full Text] [Related]
18. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
Conzen SD; Cole CN
Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
[TBL] [Abstract][Full Text] [Related]
19. The roles of urokinase-type plasminogen activator in leukocyte infiltration and inflammatory responses in mice corneas treated with lipopolysaccharide.
Sugioka K; Kodama A; Yoshida K; Okada K; Mishima H; Aomatsu K; Matsuo O; Shimomura Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5338-50. PubMed ID: 25061113
[TBL] [Abstract][Full Text] [Related]
20. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
Chang DI; Hosomi N; Lucero J; Heo JH; Abumiya T; Mazar AP; del Zoppo GJ
J Cereb Blood Flow Metab; 2003 Dec; 23(12):1408-19. PubMed ID: 14663336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
